Does Invivyd's (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility? [Yahoo! Finance]
Invivyd, Inc. (IVVD)
Company Research
Source: Yahoo! Finance
This twin index inclusion can broaden Invivyd's exposure to institutional investors and passive funds that track biotech benchmarks, potentially reshaping how the company is viewed in the sector. Next, we'll explore how Invivyd's addition to major biotechnology indices could influence its existing investment narrative and perceived growth trajectory. Uncover the next big thing with financially sound penny stocks that balance risk and reward To own Invivyd, you need to believe that its COVID 19 antibody PEMGARDA can sustain meaningful demand long enough for a broader infectious disease pipeline to take shape. The twin biotech index additions mainly affect trading visibility and liquidity, but do not materially change the near term catalyst around PEMGARDA uptake or the key risk that product concentration and regulatory uncertainty could keep Invivyd unprofitable. Among recent developments, the US$125.0 million follow on equity offering in November 2025 stands out in relation t
Show less
Read more
Impact Snapshot
Event Time:
IVVD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IVVD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IVVD alerts
High impacting Invivyd, Inc. news events
Weekly update
A roundup of the hottest topics
IVVD
News
- Invivyd (NASDAQ:IVVD) was upgraded by analysts at BTIG Research to a "strong-buy" rating.MarketBeat
- Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]Yahoo! Finance
- Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]Yahoo! Finance
- Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVIDGlobeNewswire
- Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVIDGlobeNewswire
IVVD
Earnings
- 11/6/25 - Miss
IVVD
Sec Filings
- 12/23/25 - Form 144
- 12/23/25 - Form 8-K
- 12/19/25 - Form S-3/A
- IVVD's page on the SEC website